Bharat Biotech COVID-19 vaccine approved for emergency use in children aged 12-18

FILE PHOTO: OVID-19 vaccination in New Delhi

(Reuters) - Bharat Biotech's COVID-19 vaccine Covaxin has gained approval for emergency use in children aged 12 to 18, the Indian company said on Twitter https://bit.ly/3Em588U.

The tweet came minutes after Indian Prime Minister Narendra Modi said in an address to the nation that 15-18 year olds would start receiving COVID-19 vaccinations from Jan. 3.

(Reporting by Sabahatjahan Contractor in Bengaluru; Editing by Rupam Jain and David Goodman)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting